Phone: (919) 966-8035
B.A., Transylvania University
Ph.D., University of Kentucky College of Medicine
M.D., University of Kentucky College of Medicine
Residency in Psychiatry, University of Virginia Health System
Dr. Rau is an Assistant Professor in the Department of Psychiatry and serves multiple roles for the Center for Excellence in Community Mental Health (CECMH). He is this Associate Medical Director of the new UNC STEP Community Clinic, Wake County (aka Wake STEP), which serves approximately 500 patients with severe mental illness. Dr. Rau is also the Clinical Director of the North Carolina Psychiatric Research Center (NCPRC). Wake STEP and the NCPRC are working together to provide high quality care for persons with severe mental illness and to generate clinical trials and health services research to improve health care options for these individuals. In addition, Dr. Rau continues in his role as Director of Medical Education for the CECMH. Through this role, he works with CECMH colleagues to develop and maintain a curriculum regarding the treatment of psychotic disorders and the area of community psychiatry for UNC Psychiatry resident physicians.
Dr. Rau’s current research interest centers on improving the clinical care of persons who suffer severe and persistent mental illness. Dr. Rau recently received funding from the Foundation of Hope to conduct a trial of Integrated Illness Management and Recovery; a manualized treatment designed to help persons with severe mental illness and metabolic syndrome gain better control of their physical health issues. Additionally, Dr. Rau is working with colleagues to assist in the development of a Health Services Research Core at the NCPRC to study outcomes for patients across the CECMH.
Pedersen CA, Smedley KL, Leserman J, Jarskog LF, Rau SW, Kampov-Polevoi A, Casey RL, Fender T, Garbutt JC. 2013. Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcohol Clin Exp Res. 37(3): 484-9.
- Pedersen CA, Gibson CM, Rau SW, Salimi KS, Smedley KL, Casey RL, Leserman J, Jarskog LF, Penn DL. 2011. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophrenia Research. 132(1): 50-3.
- Dubal DB*, Rau SW *, Shughrue PJ, Zhu H, Yu J, Cashion AB, Suzuki S, Gerhold L, Bottner MB, Dubal SB, Merchanthaler I, Kindy MS, and Wise PM. 2006 . Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER alpha in Estradiol-Mediated Protection Against Delayed Cell Death. Endocrinology . 147(6): 3076-3084. (*These authors contributed equally to this work)
- Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM. 2003. Estradiol attenuates markers of programmed cell death after focal cerebral ischemia. Journal of Neuroscience. 23(36): 11420-11426.